Children and adolescents with marginal zone lymphoma have an excellent prognosis with limited chemotherapy or a watch-and-wait strategy after complete resection

. 2018 Apr ; 65 (4) : . [epub] 20171229

Jazyk angličtina Země Spojené státy americké Médium print-electronic

Typ dokumentu klinické zkoušky, časopisecké články, multicentrická studie, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid29286565

Data on management of pediatric marginal zone lymphoma (MZL) are scarce. This retrospective study assessed characteristics and outcome in 66 patients who were <18 years old. Forty-four (67%) had an extranodal MZL (EMZL), 21 (32%) a nodal MZL (NMZL), and one patient a splenic MZL. Thirty-three patients (50%) received a variable combination of adjuvant chemotherapy/immunotherapy/radiotherapy, while the remainder, including 20 of 21 with NMZL, entered an active observation period. Overall survival was excellent (98 ± 2%), although 11 patients relapsed (17%; NMZL, n = 1; EMZL, n = 10), seven after any therapy and four after complete resection only. In conclusion, outcome of NZML, in particular, seems to be excellent after (in)complete resection and observation only.

Department of Pediatrics and Adolescent Medicine Li Ka Shing Faculty of Medicine Queen Mary Hospital The University of Hong Kong Pokfulam Hong Kong

Department of Pediatrics Saiseikai Yokohamashi Nanbu Hospital Yokohama Japan

Division of Hematology and Oncology Department of Pediatrics Hospital for Sick Children Toronto Canada

Division of Pediatrics Hematology and Oncology University Medical Center Ljubljana Ljubljana Slovenia

Northern Institute for Cancer Research Newcastle University Newcastle UK

Pediatric Hematology and Oncology Charles University and University Hospital Motol Prague Czech Republic

Pediatric Hematology and Oncology Erasmus MC Sophia Children's Hospital Rotterdam The Netherlands

Pediatric Hematology and Oncology Hopital Universitaire des Enfants Reine Fabiola Brussels Belgium

Pediatric Hematology and Oncology Schneider Children's Medical Center of Israel Petah Tivka Israel

Pediatric Hematology and Oncology St Anna Children's Hospital Medical University of Vienna Vienna Austria

Pediatric Hematology and Oncology The Queen Silvia's Hospital for Children and Adolescents University of Göteborg Göteborg Sweden

Pediatric Hematology and Oncology University Children's Hospital School of Medicine University of Belgrade Belgrade Serbia

Pediatric Hematology and Oncology University Hospital Saint Etienne France

Pediatric Hematology and Oncology University of Münster Münster Germany

Pediatric Hematology and Oncology University of Padova Padova Italy

Sackler Faculty of Medicine Tel Aviv University Tel Aviv Israel

Citace poskytuje Crossref.org

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...